Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P43490 (NAMPT_HUMAN) Homo sapiens (Human)

Nicotinamide phosphoribosyltransferase UniProtKBInterProSTRINGInteractive Modelling

491 aa; Sequence (Fasta) ; 1 identical sequence: Gorilla gorilla gorilla: A0A2I2Z4X6

Available Structures

81 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human NAMPT in complex with quercitrin and AMPcPhomo-2-mer8-490
A12;QCT;
Assess
Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) …homo-2-mer8-489
1QR;PO4; 10×EDO;
Assess
Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferas…homo-2-mer8-489
LTS;PO4;EDO;
Assess
Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphorib…homo-2-mer8-489
1XC;PO4;EDO;
Assess
Discovery of Potent and Efficacious Urea-containing Nicotinamide Phosphoribosyltransferase (NAMPT) …homo-2-mer8-489
1LJ;PO4; 10×EDO;
Assess
Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibi…homo-2-mer8-488
20R;PO4;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-488
20J;PO4;EDO;
Assess
Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human…homo-2-mer8-488
1R7;PO4;EDO;
Assess
Human NAMPT in complex with small molecule activator ZN-43-Shomo-2-mer8-488
PO4;GOL;TKF;CL;
Assess
Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl…homo-2-mer8-488
2QG;PO4;
Assess
Human NAMPT in complex with substrate NAMhomo-2-mer8-487
NCA;PO4;GOL;CL;
Assess
NAMPT co-crystal with inhibitor compound 2homo-2-mer8-487
PO4;HVM;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-487
20P;PO4; 16×EDO;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-487
20M;PO4; 12×EDO;
Assess
Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl…homo-2-mer8-487
2QF;PO4; 13×EDO;
Assess
Crystal Structure of Nicotinamide Phosphoribosyltransferase (Nampt) in Complex with Inhibitors 37homo-2-mer8-487
6TA;PO4;EDO;
Assess
Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) …homo-2-mer8-487
1QS;PO4; 10×EDO;
Assess
Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferas…homo-2-mer8-487
LWW;PO4; 19×EDO;
Assess
The crystal structure of a mutant NAMPT (G217R) in complex with an inhibitor APO866homo-2-mer8-487
DGB;PO4; 11×EDO;
Assess
Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide …homo-2-mer8-487
2HJ;PO4;EDO;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-487
20O;PO4; 10×EDO;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
DGB;PO4; 15×EDO;
Assess
The crystal structure of human Nicotinamide phosphoribosyltransferase (NAMPT) in complex with N-(4-…homo-2-mer8-487
3TQ;PO4; 13×EDO;
Assess
Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide …homo-2-mer8-487
2HL;PO4; 20×EDO;DTT;
Assess
The crystal structure of NAMPT in complex with GNE-618homo-2-mer8-487
2P1;PO4;EDO;
Assess
The crystal structure of a mutant NAMPT (G217V)homo-2-mer8-487
PO4; 11×EDO;
Assess
Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide …homo-2-mer8-487
2ZM;PO4;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
1XC;PO4; 26×EDO;
Assess
The crystal structure of a mutant NAMPT (S165F) in complex with GNE-618homo-2-mer8-487
2P1;PO4;EDO;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
PO4;EDO;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-487
20N;PO4;EDO;
Assess
The crystal structure of the mutant NAMPT G217Rhomo-2-mer8-487
PO4;EDO;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
PO4;EDO;
Assess
Structure-based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inh…homo-2-mer8-487
1LS;PO4;EDO;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
PO4;EDO;
Assess
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitorshomo-2-mer8-487
1QS;PO4; 13×EDO;
Assess
Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl…homo-2-mer8-487
2RM;PO4;
Assess
The crystal structures of a mutant NAMPT H191Rhomo-2-mer8-487
PO4;EDO;
Assess
Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibi…homo-2-mer8-487
20T;POP;PO4;
Assess
Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphorib…homo-2-mer8-487
1XD;PO4;EDO;
Assess
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A…homo-2-mer8-486
PO4;1EB;EDO;
Assess
Human NAMPT in complex with substrate NAM and small molecule activator ZN-29-Shomo-2-mer8-486
NCA;PO4;XI3;CL;
Assess
Crystal Structure of human NAMPT in complex with NVP-LVR596homo-2-mer7-485
CVJ;PO4;
Assess
Crystal Structure of human NAMPT in complex with NVP-LOD812homo-2-mer9-487
BWA;GOL;PO4;
Assess
Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide …homo-2-mer8-486
PO4;2HH;
Assess
Human NAMPT in complex with substrate NAM and small molecule activator NP-A1-Rhomo-2-mer9-486
NCA;PO4;TIE;GOL;CL;NA;
Assess
Human NAMPT in complex with substrate NAM and activator quercitrinhomo-2-mer9-486
NCA;CL;PO4;QCT;
Assess
Human NAMPT in complex with substrate NAM and small molecule activator NP-A1-Shomo-2-mer9-486
NCA;PO4;TIW;CL;GOL;
Assess
Crystal Structure of human NAMPT in complex with NVP-LTM976homo-2-mer7-484
OE4;PO4;
Assess
Human NAMPT in complex with inhibitor ZN-4-3homo-2-mer8-485
TK0;PO4;CL;GOL;
Assess
Human NAMPT in complex with nicotinic acid and phosphoribosyl pyrophosphatehomo-2-mer8-484
PRP;GOL;NIO;
Assess
Human NAMPT deletion mutant in complex with nicotinamide mononucleotide, pyrophosphate, and Mg2+homo-2-mer8-484
GOL;MG;NMN;PPV;
Assess
Crystal structure of human NAMPT with A-1326133homo-2-mer9-485
SO4;7TA;
Assess
Crystal Structure of Human NMPRTase in complex with FK866homo-2-mer9-485
DGB;
Assess
Crystal Structure of human NAMPT in complex with NVP-LQN520homo-2-mer9-485
C5V;
Assess
Human NAMPT in complex with nicotinic acid mononucleotide and phosphatehomo-2-mer9-484
GOL;NCN;PO4;CL;
Assess
Crystal structure of human NAMPT with isoindoline urea inhibitor compound 53homo-2-mer9-484
8HV;
Assess
CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH Compound 10homo-2-mer9-484
7YE;PO4;GOL;
Assess
Crystal structure of phosphorylated mimic form of human NAMPT complexed with nicotinamide mononucle…homo-2-mer9-484
MG;NMN;BEF;POP;
Assess
CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 1homo-2-mer9-484
PO4;7YK;GOL;
Assess
Crystal structure of phosphorylated mimic form of human NAMPT complexed with benzamide and phosphor…homo-2-mer9-484
MG;UNU;BEF;PRP;
Assess
Crystal structure of human NAMPT with A-1293201homo-2-mer9-484
7T7;SO4;
Assess
Crystal structure of human NAMPT with isoindoline urea inhibitor compound 5homo-2-mer9-484
8HY;
Assess
Crystal structure of human NAMPT complexed with benzamide and phosphoribosyl pyrophosphatehomo-2-mer9-484
PRP;UNU;
Assess
Crystal structure of Human NMPRTase as free-formhomo-2-mer8-483
Assess
Crystal structure of human NAMPT complexed with nicotinamide mononucleotide and pyrophosphatehomo-2-mer9-484
MG;NMN;POP;
Assess
Crystal structure of Human NMPRTase complexed with nicotinamidehomo-2-mer8-483
NCA;
Assess
Co-crystal structure of NAMPT dimer with KPT-9274homo-2-mer8-483
PO4; 14×GOL;96Q;
Assess
Crystal Structure of Human NAMPT in complex with A4276homo-2-mer8-483
SJ6;PO4;
Assess
Crystal structure of human NAMPT complexed with ADP analoguehomo-2-mer9-484
A12;
Assess
CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 9homo-2-mer9-484
PO4;7YX;EDO;
Assess
Crystal structure of Human NMPRTase complexed with 5'-phosphoribosyl-1'-pyrophosphatehomo-2-mer8-483
PRP;
Assess
Crystal Structure of human NMPRTase and its complex with NMNhomo-2-mer9-484
PO4;NMN;
Assess
Crystal structure of human NAMPT in complex with compound NAThomo-2-mer8-483
J7F;PO4;
Assess
CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 8homo-2-mer9-484
PO4;7YT;EDO;
Assess
Crystal Structure of human NAMPT in complex with NVP-LOQ594homo-2-mer9-484
CVP;
Assess
CRYSTAL STRUCTURE OF VISFATIN IN COMPLEX WITH SAR154782-RP.homo-2-mer9-483
7A0;DPO;
Assess
CRYSTAL STRUCTURE OF VISFATIN IN COMPLEX WITH SAR154782.homo-2-mer9-483
7A1;
Assess
Crystal STRUCTURE OF NAMPT IN COMPLEX WITH Compound 11homo-2-mer9-483
7Z2;PO4;CL;GOL;
Assess
Crystal structure of human NAMPT with fragment 5: (3E)-3-[(phenylamino)methylidene]oxan-2-onemonomer9-484
AOY;SO4;
Assess
Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)…monomer9-484
AQ1;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7ppe.1.Ahomo-2-mer0.909-484
7YK;100.00
Assess